mycophenolate mofetil
mycophenolate mofetil is listed in the FDA National Drug Code directory with 17 NDC codes, marketed under brand names including MYCOPHENOLATE MOFETIL, mycophenolate mofetil, Mycophenolate Mofetil. Available dosage forms: powder, for suspension, injection, powder, lyophilized, for solution, tablet, capsule, tablet, film coated.
Drug Details
- Generic Name
- mycophenolate mofetil
- Brand Names
- MYCOPHENOLATE MOFETIL, mycophenolate mofetil, Mycophenolate Mofetil
- Application Number
- ANDA218227
- Sponsor
- Aurobindo Pharma Limited
- NDC Codes
- 17
- Dosage Forms
- POWDER, FOR SUSPENSION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, TABLET, CAPSULE, TABLET, FILM COATED, POWDER
- Routes
- ORAL, INTRAVENOUS
- Active Ingredients
- MYCOPHENOLATE MOFETIL
Indications and Usage
1 INDICATIONS AND USAGE Mycophenolate mofetil for oral suspension (MMF) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ], heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ] , in combination with other immunosuppressants. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. ( 1 )